LO Selection - NextGen BioTech USD MD Fonds Kurs - 1 Jahr
Fundamentaldaten
| Valor | 58527957 |
| ISIN | LU2265257266 |
| Name | LO Selection - NextGen BioTech USD MD Fonds |
| Fondsgesellschaft | Lombard Odier Funds |
| Aufgelegt in | Luxembourg |
| Auflagedatum | 14.01.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 256’702’623.30 |
| Depotbank | CACEIS Bank, Luxembourg Branch |
| Zahlstelle | Bank Lombard Odier & Co AG |
| Fondsmanager | Jérôme Berton |
| Geschäftsjahresende | 30.09. |
| Berichtsstand | 31.05.2023 |
Anlagepolitik
So investiert der LO Selection - NextGen BioTech USD MD Fonds: The Sub-Fund invests primarily in equity securities or equity-related securities issued by companies worldwide (including Emerging Markets) exercising a prominent part of their business activities in the healthcare industry. The Investment Manager’s approach focuses on small and mid-cap biotechnology companies providing positive impact through disruptive, next generation innovations that can bring, among other things, better treatment solutions while lowering the financial burden for society.